Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)

ZA Sherif, CR Gomez, TJ Connors, TJ Henrich… - Elife, 2023 - elifesciences.org
COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …

Long COVID: a clinical update

T Greenhalgh, M Sivan, A Perlowski, JŽ Nikolich - The Lancet, 2024 - thelancet.com
Summary Post-COVID-19 condition (also known as long COVID) is generally defined as
symptoms persisting for 3 months or more after acute COVID-19. Long COVID can affect …

Diagnosis and treatment of acute myocarditis: a review

E Ammirati, JJ Moslehi - Jama, 2023 - jamanetwork.com
Importance Acute myocarditis, defined as a sudden inflammatory injury to the myocardium,
affects approximately 4 to 14 people per 100 000 each year globally and is associated with …

Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus …

B Heidecker, N Dagan, R Balicer… - European journal of …, 2022 - Wiley Online Library
Over 10 million doses of COVID‐19 vaccines based on RNA technology, viral vectors,
recombinant protein, and inactivated virus have been administered worldwide. Although …

Postural orthostatic tachycardia syndrome as a sequela of COVID-19

CK Ormiston, I Świątkiewicz, PR Taub - Heart Rhythm, 2022 - Elsevier
Postural orthostatic tachycardia syndrome (POTS) is a complex multisystem disorder
characterized by orthostatic intolerance and tachycardia and may be triggered by viral …

Impact of COVID-19 on cardiovascular disease

I Vosko, A Zirlik, H Bugger - Viruses, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …

[HTML][HTML] Long COVID and rehabilitation

HJ Chuang, CW Lin, MY Hsiao, TG Wang… - Journal of the Formosan …, 2024 - Elsevier
Coronavirus disease 2019 (COVID-19) has caused tremendous morbidity and mortality
worldwide. The large number of post-COVID survivors has drawn attention to the …

Clinical trials on the pharmacological treatment of long COVID: A systematic review

YJ Chee, BE Fan, BE Young, R Dalan… - Journal of Medical …, 2023 - Wiley Online Library
The postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
infection (PASC), also known as post‐acute coronavirus disease 19 (COVID‐19) or the long …

[HTML][HTML] COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities

K Bardosh, A Krug, E Jamrozik, T Lemmens… - Journal of Medical …, 2024 - jme.bmj.com
In 2022, students at North American universities with third-dose COVID-19 vaccine
mandates risk disenrolment if unvaccinated. To assess the appropriateness of booster …

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

B Raman, C McCracken, MP Cassar… - The Lancet …, 2023 - thelancet.com
Introduction The multiorgan impact of moderate to severe coronavirus infections in the post-
acute phase is still poorly understood. We aimed to evaluate the excess burden of …